| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 36 |
| 1 | METHOTREXATE | 33 |
| 2 | PREDNISONE | 23 |
| 3 | ADALIMUMAB | 17 |
| 4 | SECUKINUMAB | 15 |
| 5 | THALIDOMIDE | 15 |
| 6 | FOLIC ACID | 12 |
| 7 | INFLIXIMAB | 12 |
| 8 | GOLIMUMAB | 11 |
| 9 | RIFAMPICIN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLURANDRENOLIDE | 1 | 0.0030 |
| 1 | NITAZOXANIDE | 1 | 0.0029 |
| 2 | RIFAMPICIN | 11 | 0.0011 |
| 3 | CLOFAZIMINE | 6 | 0.0009 |
| 4 | DASPONE | 9 | 0.0009 |
| 5 | DAPSONE GEL, 5% | 9 | 0.0009 |
| 6 | GOLIMUMAB | 11 | 0.0009 |
| 7 | DAPSONE | 9 | 0.0008 |
| 8 | ACITRETIN | 4 | 0.0008 |
| 9 | NEVIRAPINE | 6 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Sulfone [EPC] | 9 | 0.0008 |
| 2 | Antimycobacterial [EPC] | 12 | 0.0005 |
| 3 | Interleukin-17A Antagonist [EPC] | 16 | 0.0004 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0004 |
| 5 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |
| 7 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 8 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |